Literature DB >> 15131130

Role of nuclear factor-kappaB in the antiviral action of interferon and interferon-regulated gene expression.

Lawrence M Pfeffer1, Jong-Gwan Kim, Susan R Pfeffer, Dennis J Carrigan, Darren P Baker, Lai Wei, Ramin Homayouni.   

Abstract

Interferons (IFNs) play critical roles in host defense by modulating the expression of various genes via tyrosine phosphorylation of STAT transcription factors. IFN-alpha/beta activates another important transcription factor, nuclear factor-kappaB (NF-kappaB), but its role in IFN-mediated activity is poorly understood. Sensitivity to the antiviral and gene-inducing effects of IFN was examined in normal fibroblasts and in NF-kappaB knockout fibroblasts from p50- and p65-null mice. Antiviral assays demonstrated that NF-kappaB knockout fibroblasts were sensitized to the antiviral action of IFN. Moreover, analysis of IFN-stimulated gene expression by real-time PCR demonstrated selective effects of NF-kappaB on gene expression. Our results demonstrate that a subset of IFN-stimulated genes is regulated through an NF-kappaB-dependent pathway and that NF-kappaB may regulate the sensitivity of cells to IFN-mediated antiviral activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15131130     DOI: 10.1074/jbc.M308975200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

Review 1.  The role of nuclear factor κB in the interferon response.

Authors:  Lawrence M Pfeffer
Journal:  J Interferon Cytokine Res       Date:  2011-06-01       Impact factor: 2.607

2.  Distinct roles for the NF-kappa B RelA subunit during antiviral innate immune responses.

Authors:  Suresh H Basagoudanavar; Roshan J Thapa; Shoko Nogusa; Junmei Wang; Amer A Beg; Siddharth Balachandran
Journal:  J Virol       Date:  2011-01-05       Impact factor: 5.103

3.  Interferon alpha activates NF-kappaB in JAK1-deficient cells through a TYK2-dependent pathway.

Authors:  Chuan He Yang; Aruna Murti; William J Valentine; Ziyun Du; Lawrence M Pfeffer
Journal:  J Biol Chem       Date:  2005-05-09       Impact factor: 5.157

4.  Interferon-alpha induces up-regulation and nuclear translocation of the Ro52 autoantigen as detected by a panel of novel Ro52-specific monoclonal antibodies.

Authors:  Linn Strandberg; Aurelie Ambrosi; Alexander Espinosa; Lars Ottosson; Maija-Leena Eloranta; Wei Zhou; Ase Elfving; Edward Greenfield; Vijay K Kuchroo; Marie Wahren-Herlenius
Journal:  J Clin Immunol       Date:  2008-05       Impact factor: 8.317

5.  Role of IRF4 in IFN-stimulated gene induction and maintenance of Kaposi sarcoma-associated herpesvirus latency in primary effusion lymphoma cells.

Authors:  Adriana Forero; Patrick S Moore; Saumendra N Sarkar
Journal:  J Immunol       Date:  2013-06-26       Impact factor: 5.422

6.  IQGAP2 is a novel interferon-alpha antiviral effector gene acting non-conventionally through the NF-κB pathway.

Authors:  Cynthia Brisac; Shadi Salloum; Victor Yang; Esperance A K Schaefer; Jacinta A Holmes; Stephane Chevaliez; Jian Hong; Charlie Carlton-Smith; Nadia Alatrakchi; Annie Kruger; Wenyu Lin; Raymond T Chung
Journal:  J Hepatol       Date:  2016-07-09       Impact factor: 25.083

7.  Interferon induces NF-kappa B-inducing kinase/tumor necrosis factor receptor-associated factor-dependent NF-kappa B activation to promote cell survival.

Authors:  Chuan He Yang; Aruna Murti; Lawrence M Pfeffer
Journal:  J Biol Chem       Date:  2005-07-11       Impact factor: 5.157

8.  A phosphorylation-acetylation switch regulates STAT1 signaling.

Authors:  Oliver H Krämer; Shirley K Knauer; Georg Greiner; Enrico Jandt; Sigrid Reichardt; Karl-Heinz Gührs; Roland H Stauber; Frank D Böhmer; Thorsten Heinzel
Journal:  Genes Dev       Date:  2009-01-15       Impact factor: 11.361

9.  The alpha/beta interferon receptor provides protection against influenza virus replication but is dispensable for inflammatory response signaling.

Authors:  Alan G Goodman; Hui Zeng; Sean C Proll; Xinxia Peng; Cristian Cillóniz; Victoria S Carter; Marcus J Korth; Terrence M Tumpey; Michael G Katze
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

10.  Interferons and their potential in the treatment of ocular inflammation.

Authors:  Friederike Mackensen; Regina Max; Matthias D Becker
Journal:  Clin Ophthalmol       Date:  2009-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.